MTOR and acute lymphoblastic leukemia: Next, l-asparaginase, a molecule used in the treatment of acute lymphoblastic leukaemia (ALL), has the capacity to hydrolyse glutamine, besides the degradation of asparagine, and leads to an intracellular depletion of amino acids and inhibition of mTOR activity [74,75,76].